CDEK
← All organizations

Keryx

For profitContributed to NME

Also known as: Keryx, | Keryx Biopharmaceuticals | KERYX BIOPHARMS

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Oct 1, 2002

First marketed drug

Sep 5, 2014

First NDA

Sep 5, 2014

Last known activity

Feb 28, 2021

Acquired by Akebia Therapeutics on Jun 29, 2018

Timeline

1990s

  1. Jul 1, 1997

    Keryx— Founded

2000s

  1. Jan 19, 2004

    AOI Pharmaceuticals, Inc.— Acquired

2010s

  1. Sep 5, 2014

    ferric citrate— NDA Organization

  2. Sep 5, 2014

    ferric citrate— NDA Secondary Org

  3. Jun 29, 2018

    Akebia Therapeutics— Acquired By

Drugs by trial phase (12 distinct, 27 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (2 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (26)

Details

Founded
Boston, MA, US Jul 1, 1997
First NDA
Sep 5, 2014
Last known activity
Feb 28, 2021

Notes

Acquired by Akebia 28 June 2018